Black Hawk Acquisition CORP 8-K filings

Black Hawk Acquisition Corporation has deposited $150,000 to extend its deadline for consummating an initial business combination by one month.

Black Hawk Acquisition Corporation received a notice from Nasdaq regarding non-compliance with the $50 million market value of listed securities requirement.

Vesicor Therapeutics, a proposed de-SPAC target for Black Hawk Acquisition Corp., has appointed Dr. Michael Tolentino, a seasoned biotech leader, as its new Chief Executive Officer.

Black Hawk Acquisition Corporation has secured a convertible promissory note of up to $300,000 from its sponsor, Black Hawk Management LLC, for working capital.

Black Hawk Acquisition Corporation's proposed business combination target, Vesicor Therapeutics, Inc., announced the appointment of Mitchell Creem as Chief Financial Officer and Frederick Woodruff Field as an independent director.

Black Hawk Acquisition Corporation has extended the deadline to complete its initial business combination by one month to October 22, 2025, following a $150,000 trust account deposit.

Black Hawk Acquisition Corporation has extended its deadline to complete an initial business combination by one month to September 22, 2025, by depositing $150,000 into its trust account.

Black Hawk Acquisition Corporation has extended its deadline to complete an initial business combination to August 22, 2025, by depositing $150,000 into its trust account.

Black Hawk Acquisition Corporation filed an amended 8-K to clarify details of its recent share redemption, revealing that 4.78 million shares were redeemed for approximately $51 million from its Trust Account.

Black Hawk Acquisition Corporation secured shareholder approval to extend its business combination deadline until December 22, 2026, but faced substantial share redemptions, significantly reducing its trust account balance.

Black Hawk Acquisition Corporation has amended its definitive proxy statement to establish a fixed $150,000 monthly deposit for extending its business combination deadline, replacing a variable per-share amount.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders to July 8, 2025, to gather more votes on key proposals.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders to July 3, 2025, to allow for the solicitation of additional votes on key matters.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders from June 27, 2025, to July 1, 2025, to allow for the solicitation of additional votes on key proposals.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders to June 27, 2025, to allow for the solicitation of additional votes on key proposals.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders to later today, June 23, 2025, to allow for the solicitation of additional votes on key proposals.

Black Hawk Acquisition Corporation has filed a supplement to its definitive proxy statement, amending the language of its Trust Amendment Proposal to remove discretion on extension fees and set a fixed contribution rate for extending its business combination deadline.

Black Hawk Acquisition Corporation has adjourned its Extraordinary General Meeting of Shareholders to June 23, 2025, to allow for further solicitation of votes on key proposals.

Black Hawk Acquisition Corporation reported the passing of a board member and Audit Committee Chairperson, leading to immediate appointments to ensure continuity in corporate governance.

Black Hawk Acquisition Corp. and Vesicor Therapeutics have entered into a business combination agreement, paving the way for Vesicor to become a publicly traded company focused on p53-based cancer therapeutics.

Black Hawk Acquisition Corporation has appointed Jonathan Ginsberg as its Chief Operating Officer and a member of the Board of Directors, effective immediately.

Black Hawk Acquisition Corporation has appointed Jonathan Ginsberg as its Chief Operating Officer and a member of the Board of Directors, effective immediately.

Black Hawk Acquisition Corporation filed an amendment to its original 8-K report to correct the number of private placement units purchased by the sponsor.

Black Hawk Acquisition Corporation successfully closed its initial public offering and a concurrent private placement, raising a total of $71.355 million.

Black Hawk Acquisition Corporation successfully closed its $69 million initial public offering and amended its rights agreement, detailing the terms for future share issuance upon a business combination.